SCHEMBL5731723

SCHEMBL5731723

Cc1cc2c(s1)Cc1ccccc1NC2=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 1/20 0.45
PDK2 Q15119 1/20 0.45
ACVR1 Q04771 2/20 0.42
LRRK2 Q5S007 2/20 0.42
ROS1 P08922 1/20 0.42
CDK5 Q00535 1/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
RAB9A P51151 2/20 0.41
NPC1 O15118 2/20 0.41
MAPK1 P28482 2/20 0.41
MAPT P10636 2/20 0.41
KDM4E B2RXH2 2/20 0.41
HSP90AA1 P07900 1/20 0.41
THRB P10828 1/20 0.41
HK1 P19367 1/20 0.41
RECQL P46063 1/20 0.41
GALK1 P51570 1/20 0.41
BLM P54132 1/20 0.41
HKDC1 Q2TB90 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5922026 0.82 AHR (0.41) AHRPDK2ACVR1LRRK2ROS1
SCHEMBL7411028 0.76 AHR (0.52) AHRPDK2ACVR1LRRK2MEN1
SCHEMBL4479100 0.74 CHEK1 (0.42) LRRK2CDK5RAB9ANPC1MAPT
SCHEMBL1728316 0.73 CDK5 (0.51) ACVR1LRRK2ROS1CDK5MEN1
SCHEMBL29927169 0.73 CDK5 (0.51) ACVR1LRRK2ROS1CDK5MEN1
SCHEMBL5922041 0.72 AHR (0.44) AHRPDK2LRRK2CDK5MEN1
SCHEMBL2087698 0.72 TDP2 (0.66) AHRPDK2ACVR1LRRK2MEN1
SCHEMBL19486031 0.69 MEN1 (0.49) AHRPDK2MEN1KMT2ARAB9A
SCHEMBL1816980 0.68 AHR (0.63) AHRPDK2ACVR1LRRK2MEN1
SCHEMBL17339888 0.68 ALDH1A1 (0.34) LRRK2CDK5MEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060270656-A1 Substituted piperazines of azepines, oxazepines and thiazepines ELI LILLY AND COMPANY 2006-11-30 US disclosed
EP-1664063-A1 SUBSTITUTED PIPERAZINES OF AZEPINES, OXAZEPINES, AND THIAZEPINES ELI LILLY AND COMPANY (US) 2006-06-07 EP disclosed
WO-2005026177-A1 SUBSTITUTED PIPERAZINES OF AZEPINES, OXAZEPINES, AND THIAZEPINES ELI LILLY AND COMPANY (US) 2005-03-24 WO disclosed
EP-0001401-A1 Thienobenzazepine derivatives, processes for their production and pharmaceutical compositions containing them SANDOZ AG (CH) 1979-04-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060270656-A1 Substituted piperazines of azepines, oxazepines and thiazepines HRH4, HRH2, HRH3 AHR 81/4885PDK2 2219/4885ACVR1 1314/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.